Cirrhosis tertiary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Cirrhosis}} {{CMG}}; {{AE}} {{Cherry}} ==Tertiary Prevention== ===Overview=== Tertiary prevention in patients with cirrhosis is aimed at preventin..." |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Cirrhosis}} | {{Cirrhosis}} | ||
{{CMG}}; {{AE}} {{Cherry}} | {{CMG}}; {{AE}} {{Cherry}} | ||
==Overview== | |||
Tertiary prevention in [[Patient|patients]] with [[cirrhosis]] is aimed at preventing the complications that arise from [[cirrhosis]], such as [[esophageal varices]], [[spontaneous bacterial peritonitis]], [[hepatorenal syndrome]] and [[portal vein thrombosis]]. | Tertiary prevention in [[Patient|patients]] with [[cirrhosis]] is aimed at preventing the complications that arise from [[cirrhosis]], such as [[esophageal varices]], [[spontaneous bacterial peritonitis]], [[hepatorenal syndrome]] and [[portal vein thrombosis]]. | ||
==Tertiary Prevention== | |||
* Non-selective [[beta blockers]] reduce the risk of further [[bleeding]] from the [[esophageal varices]].<ref name="pmid20536715">{{cite journal |vauthors=Muntaner L, Altamirano JT, Augustin S, González A, Esteban R, Guardia J, Genescà J |title=High doses of beta-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding |journal=Liver Int. |volume=30 |issue=8 |pages=1123–30 |year=2010 |pmid=20536715 |doi=10.1111/j.1478-3231.2010.02287.x |url=}}</ref> | * Non-selective [[beta blockers]] reduce the risk of further [[bleeding]] from the [[esophageal varices]].<ref name="pmid20536715">{{cite journal |vauthors=Muntaner L, Altamirano JT, Augustin S, González A, Esteban R, Guardia J, Genescà J |title=High doses of beta-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding |journal=Liver Int. |volume=30 |issue=8 |pages=1123–30 |year=2010 |pmid=20536715 |doi=10.1111/j.1478-3231.2010.02287.x |url=}}</ref> | ||
Latest revision as of 14:29, 26 December 2017
|
Cirrhosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Cirrhosis tertiary prevention On the Web |
|
American Roentgen Ray Society Images of Cirrhosis tertiary prevention |
|
Risk calculators and risk factors for Cirrhosis tertiary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]
Overview
Tertiary prevention in patients with cirrhosis is aimed at preventing the complications that arise from cirrhosis, such as esophageal varices, spontaneous bacterial peritonitis, hepatorenal syndrome and portal vein thrombosis.
Tertiary Prevention
- Non-selective beta blockers reduce the risk of further bleeding from the esophageal varices.[1]
- Judicious use of diuretics and prophylactic antibiotics prevent spontaneous bacterial peritonitis.
- Avoiding vigorous diuresis and nephrotoxic drugs help to prevent hepatorenal syndrome.
- Enoxaparin, a low molecular weight heparin, is effective in the prevention of portal vein thrombosis in patients with cirrhosis.
- Adequate nutrition in patients with alcoholic cirrhosis decreases the risk of major complications, such as ascites, encephalopathy, and infections.
References
- ↑ Muntaner L, Altamirano JT, Augustin S, González A, Esteban R, Guardia J, Genescà J (2010). "High doses of beta-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding". Liver Int. 30 (8): 1123–30. doi:10.1111/j.1478-3231.2010.02287.x. PMID 20536715.